Cutler Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Cutler Group’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,500	Closed	-$2K	–	5198
2022 Q2	$2K	Buy	+2,500	New	+$29.5K	﹤0.01%	4295
2022 Q1	–	Sell	-10,000	Closed	-$2K	–	5657
2021 Q4	$2K	Hold	10,000	–	–	﹤0.01%	4754
2021 Q3	$7K	Hold	10,000	–	–	﹤0.01%	4211
2021 Q2	$13K	Hold	10,000	–	–	﹤0.01%	3680
2021 Q1	$9K	Hold	10,000	–	–	﹤0.01%	3887
2020 Q4	$14K	Buy	+10,000	New	+$109K	﹤0.01%	2934
2017 Q2	–	Sell	-11,701	Closed	-$4K	–	6668
2017 Q1	$4K	Buy	+11,701	New	+$160K	﹤0.01%	4899
2016 Q4	–	Sell	-7,642	Closed	-$3K	–	6897
2016 Q3	$3K	Sell	7,642 -1,552	-17%	-$18.1K	﹤0.01%	5375
2016 Q2	$5K	Buy	9,194 +5,612	+157%	+$54.8K	﹤0.01%	4929
2016 Q1	$1K	Buy	+3,582	New	+$29.5K	﹤0.01%	6003

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cutler Group's IRWD Position: Q3 2020 in Review

Cutler Group sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2020, closing a stake of 5,300 shares — an estimated $54K sold.

Cutler Group first reported a position in IRWD in Q4 2015 and held it in 7 quarters. The position peaked at $54K in Q2 2020. 190 funds tracked by Wall St. Rank hold IRWD as of Q3 2020.

Cutler Group reported no remaining Ironwood Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Cutler Group sold 5,300 Ironwood Pharmaceuticals shares in Q3 2020, an estimated $54K.
Cutler Group first reported a position in Ironwood Pharmaceuticals in Q4 2015 and held it in 7 quarters.
Cutler Group's Ironwood Pharmaceuticals position peaked at $54K in Q2 2020.
190 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2020.

Based on Cutler Group's 13F filing for Q3 2020, filed 27 Oct 2020.